Nationality Indian Religion Hindu Spouse(s) Vandana Trivedi Name Piyush Trivedi | Children 2 daughters, 1 son Residence Bhopal Profession Academician | |
 | ||
Born 13 September 1958 (age 65)
Indore, Madhya Pradesh ( 1958-09-13 ) Alma mater Dr. Hari Singh Gour University Education Dr. Hari Singh Gour University | ||
Piyush trivedi pal pal dil k pass
Piyush Trivedi is an Indian academician and educationist. He was Founder Head of the School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal and is currently the Vice Chancellor of Rajiv Gandhi Proudyogiki Vishwavidyalaya, the University of Technology of Madhya Pradesh.
Contents
- Piyush trivedi pal pal dil k pass
- Prof piyush trivedi hon vc rgpv bhopal exclusive interview with lead news tablet itdc
- Education
- Career
- References
Prof piyush trivedi hon vc rgpv bhopal exclusive interview with lead news tablet itdc
Education
He did his B.Pharm from Holkar Science College, Devi Ahilya Vishwavidyalaya in 1979 in Pharmaceutical Chemistry and then his M.Pharm, Sagar University in 1981 in Pharmaceutical Chemistry. Afterwards, He did his Ph.D in 1992 from, Devi Ahilya Vishwavidyalaya (Formerly Indore University) in 1992.
Career
In the year 2003, he joined RGTU as the Founder Head of the School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal and is currently serving as the Vice Chancellor of Rajiv Gandhi Proudyogiki Vishwavidyalaya, the University of Technology of Madhya Pradesh.
Prof. Trivedi is also serving as the Director of M.P. Power Generating Co. Ltd. since the year 2009. Trivedi is also involved in various capacities, such as member of Regional Committee of AICTE and member of Executive Council of M.P. Council of Science & Technology.
In December,2015 Rajiv Gandhi Proudyogiki Vishwavidyalaya Vice Chancellor Trivedi and his doctoral student claimed to have discovered cancer curing molecules from turmeric through their research which lasted for about 10 years. They filed a US Patent for their two molecules namely "CTR-17" and "CTR-20". They claimed that the molecules selectively target the cancer cells and have no significant side effects as the molecules elicit anticancer activity through a mechanism which involves obstruction of cancer cell division by inhibition of tubulin, a protein which is responsible for many of the cell functions including chromosome segregation during cell division, development and maintenance of cell shape, intracellular transport, distribution of molecules on cell membranes and cell motility.